Recent Publications
Belknap SM, Georgopoulos CH, West DP,
Yarnold PR and Kelly WN. Quality of Methods of Reporting Adverse
Drug Events in Cancer Drug Clinical Trials. Clinical Pharmacology
and Therapeutics. Submitted 2010.
Kelly WN, Grissinger M, and Phillips M.
Look-alike drug name errors - Is enhanced lettering the answer? J
Quality and Patient Safety. Submitted 2010.
Kelly WN, Arellano FM, Barnes J, Bergman
U, Edwards IR, Fernandez SB, Goldsmith DI, Huang KA, Jones JK,
McLeay R, Moore N, Stather RH, Trenque T, Troutman WG, van
Puijenbroek E, Williams F, and Wise RP.
Guidelines for Submitting Adverse Event Reports for Publication.
Therapie. 2009;64(4):289-294.
Kelly WN,
Arellano FM, Barnes J, Bergman U, Edwards IR, Fernandez SB,
Goldsmith DI, Huang KA, Jones JK, McLeay R, Moore N, Stather RH,
Trenque T, Troutman WG, van Puijenbroek E, Williams F, and Wise RP.
Guidelines for
Submitting Adverse Event Reports for Publication.
Drug Safety. 2007;30(5):367-373.
Kelly WN. Pharmacy: What It Is and How
It Works. CRC Publishing Company, Boca Raton, Florida. 2nd Edition,
2002, 2007.
Kelly WN. Prescribed Medication
and the Public Health: Laying the Foundation for Risk Reduction.
Haworth Press, Binghamton, NY. 2006.
Kelly WN.
Compelling Features of a Safe Medication Use System. American Journal of Health-System
Pharmacists. 2006;63(15):1461-1468.
Kelly WN.
The Role of Pharmacoepidemiology in Drug Injury and Expert
Testimony. Chapter 11 in Drug Injury: Liability, Analysis and
Prevention. Second Edition. Edited by James T. O’Donnell. Lawyers
and Judges Publishing Company. Tucson, AZ. 2005.
Al-Tajir G
and Kelly WN.
Epidemiology,
Comparative Methods of
Detection, and
Preventability of Adverse Drug Events at Al Qassimi Hospital.
Annals of
Pharmacotherapy. 2005;39(7):1169-1174.
Kelly WN.
Medication Errors: Lessons Learned and Actions
Needed.
Professional Safety. 2004;49(7):35-41.
Kelly
WN.
The Quality of Published Adverse Drug Event Reports. Annals
of Pharmacotherapy. 2003;37(12):1774-1778.